 |
|
Neurofibrillary Pathology in Alzheimer Disease With Lewy Bodies
Two Subgroups
Marla Gearing, PhD;
Michael Lynn, MS;
Suzanne S. Mirra, MD
Arch Neurol. 1999;56:203-208.
Background While NFT frequency is reportedly reduced in AD+DLB, we often encounter abundant neocortical NFTs in such cases and decided to investigate this discrepancy.
Objective To compare neurofibrillary tangle (NFT) frequency in Alzheimer disease with concomitant dementia with Lewy bodies (AD+DLB) with NFT frequency in "pure" AD.
Methods Neurofibrillary tangle frequency, as well as regional staging of neurofibrillary degeneration modified from Braak, was scored in 160 autopsy cases of primary dementia (80 AD+DLB cases and 80 pure AD cases).
Results Neurofibrillary tangle and modified Braak scores were lower in AD+DLB, as reported previously. Yet, neocortical NFT scores assumed markedly different patterns in the 2 groups (P=.001). In pure AD, NFT scores of "frequent" were predominant: more cases exhibited frequent than moderate or sparse NFTs. In AD+DLB, the distribution of NFT scores was bimodal: NFTs were either frequent or few to absent. Neocortical NFT scores in the AD+DLB group tended to parallel the severity of other types of tau cytopathology (neuropil threads and tau-positive plaque neurites).
Conclusions Cases of AD+DLB may be divided into 2 subgroups based on the extent of neocortical neurofibrillary pathology. These findings could have implications for disease pathogenesis and treatment.
From the Veterans Affairs Medical Center and the Department of Pathology and Laboratory Medicine, Emory University School of Medicine (Dr Gearing), and the Department of Biostatistics, Emory University School of Public Health (Mr Lynn), Atlanta, Ga, and the Department of Pathology, State University of New York Health Science Center at Brooklyn (Dr Mirra).
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(2):254-255.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Decreased CSF amyloid {beta}42 and normal tau levels in dementia with Lewy bodies
Tschampa et al.
Neurology 2001;56:576-576.
FULL TEXT
Cortical Inflammation in Alzheimer Disease but Not Dementia With Lewy Bodies
Shepherd et al.
Arch Neurol 2000;57:817-822.
ABSTRACT
| FULL TEXT
Cholinergic dysfunction in diseases with Lewy bodies
Tiraboschi et al.
Neurology 2000;54:407-407.
ABSTRACT
| FULL TEXT
Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX
Heyman et al.
Neurology 1999;52:1839-1839.
ABSTRACT
| FULL TEXT
|
